[Brain natriuretic peptide as a predictor of heart failure in patients with permanent pacemaker]
| Autor: | Vera Jelic, Goran Milasinovic, Mirjana Zivkovic, Sinisa U. Pavlovic, Vladimir Kanjuh |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Male
medicine.medical_specialty Pacemaker Artificial lcsh:Medicine pacemaker therapy brain natriuretic peptide Ddd pacing Predictive Value of Tests Statistical significance Internal medicine Natriuretic Peptide Brain medicine Humans In patient cardiovascular diseases Normal range Aged Heart Failure business.industry lcsh:R Dilated cardiomyopathy General Medicine Middle Aged medicine.disease Brain natriuretic peptide Heart failure Cardiology Exercise Test Female Permanent pacemaker business human activities hormones hormone substitutes and hormone antagonists Biomarkers |
| Zdroj: | Srpski Arhiv za Celokupno Lekarstvo, Vol 135, Iss 1-2, Pp 21-25 (2007) Europe PubMed Central |
| ISSN: | 0370-8179 |
| Popis: | Introduction: Brain natriuretic peptide (BNP) has a role in control of cardiovascular and renal functions. Objective The objective was to assess the predictive value of BNP levels for development of heart failure in patients with permanent pacemakers. Method In patients with implanted DDD pacemakers, BNP levels were measured at rest and after exercise testing, on DDD and VVI modes. There were 42 patients (25 males; 59.5%), without symptoms or signs of coronary disease or heart failure, and with normal echocardiograms. According to BNP levels, the patients were divided into three groups: with BNP levels lower than 80 pg/ml, BNP ranging from 81-150 pg/ml, and BNP levels over 151 pg/ml. Results In the first group (27 patients), BNP levels were significantly higher on VVI compared to DDD mode, both at rest and after exercise (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|